CELH
Celsius Holdings, Inc.
CELH has the edge over COUR overall, supported by stronger fundamentals and stronger valuation.
COUR
Coursera, Inc.
COUR's outlook is improving, though it still trails on the overall score.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
COUR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Under pressure | |
| Unavailable |
COUR's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
COUR PE Valuation
COUR has no meaningful PE right now: it lost money over the past year.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
CELH has the edge over COUR on the outlook, with more favorable profitability expectations.
COUR Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect strong earnings and revenue growth for COUR, with profitability holding steady. However, they disagree widely on these estimates.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH has the edge over COUR on earnings quality, reporting a profit while its opponent remains loss making.
COUR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.59 | — |
| Q3 2026 | -$0.72 | -$0.44 |
| Q2 2026 | -$0.67 | -$0.35 |
| Q1 2026 | -$0.38 | +$0.04 |
| Q4 2025 | -$0.31 | +$0.20 |
| Q3 2025 | -$0.28 | +$0.23 |
| Q2 2025 | -$0.32 | +$0.31 |
| Q1 2025 | -$0.42 | +$0.27 |
| Q4 2024 | -$0.51 | +$0.26 |
COUR lost $0.72 per share over the past year, and its loss has widened in each of the last four quarters.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH's revenue has grown year over year for six quarters in a row: $847M last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over COUR on profitability, with a higher operating margin.
COUR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $376.7M | +94% |
| Q2 2026 | $298.6M | +60% |
| Q1 2026 | $195.7M | +9.1% |
| Q4 2025 | $196.9M | +9.9% |
| Q3 2025 | $194.2M | +10% |
| Q2 2025 | $187.1M | +9.8% |
| Q1 2025 | $179.3M | +6.1% |
| Q4 2024 | $179.2M | +6.1% |
COUR's revenue has grown year over year every quarter since early 2021: $377M last quarter, up 94% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.7% | +0.4 points |
| Q2 2026 | -28% | -20 points |
| Q1 2026 | -13% | -4.9 points |
| Q4 2025 | -16% | +0.6 points |
| Q3 2025 | -8% | +4.3 points |
| Q2 2025 | -8.1% | +10 points |
| Q1 2025 | -8% | +9.6 points |
| Q4 2024 | -17% | -0.1 points |
COUR's operating margin was −7.7% last quarter, about level with the same quarter a year ago, near the top of its range since 2020.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH has the edge over COUR on cash flow, with stronger typical year-over-year growth.
COUR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $15.2M | -55% |
| Q2 2026 | -$20.1M | -157% |
| Q1 2026 | $14.4M | -56% |
| Q4 2025 | $5.4M | -70% |
| Q3 2025 | $33.7M | +22% |
| Q2 2025 | $35.1M | +48% |
| Q1 2025 | $33M | +36% |
| Q4 2024 | $18.1M | +58% |
COUR still generates free cash flow, though less than at its 2025 peak: $15M over the past year.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has the edge over COUR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
COUR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +13% | +31.3M shares |
| 1 year | +61% | +100M shares |
| 3 years | +75% | +114M shares |
| 5 years | +101% | +133M shares |
| Available history | +542% | +223M shares |
COUR has 265M diluted shares, up 61% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $103.4M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | $31.1M |
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
COUR Net Leverage
COUR's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
COUR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.2 | Neutral |
| Stochastic | 4.4 | Oversold |
COUR's weekly RSI is 31 (neutral) and its Stochastic is 4 (oversold).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
COUR PE vs Consumer Defensive Sector
COUR has no meaningful PE right now: it lost money over the past year.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has the edge over COUR on trend strength, trading above more of its moving averages.
COUR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.50 | 21% below |
| 20 week MA | $5.20 | 32% below |
| 50 week MA | $5.79 | 39% below |
| 100 week MA | $7.39 | 52% below |
| 200 week MA | $10.1 | 65% below |
COUR is in a downtrend: it's below all five of its weekly moving averages, and 65% below its 200-week average.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH has the edge over COUR on returns for 2026, with the stronger performance.
COUR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $45.8 | $25.1 | -45% |
| 2022 | $25.1 | $12.1 | -52% |
| 2023 | $12.1 | $19.4 | +61% |
| 2024 | $19.4 | $8.39 | -57% |
| 2025 | $8.39 | $7.43 | -11% |
| 2026 YTD | $7.43 | $3.56 | -52% |
COUR has finished lower in four of the last five years. It's down 52% so far in 2026.